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Background and Purpose Migraine has been shown to increase cerebral excitability, promote 
rapid infarct expansion into tissue with perfusion deficits, and result in larger infarcts in animal 
models of focal cerebral ischemia. Whether these effects occur in humans has never been 
properly investigated. 
Methods In a series of consecutive patients with acute ischemic stroke, enrolled in the setting of 
the Italian Project on Stroke at Young Age, we assessed acute as well as chronic infarct volumes by 
volumetric magnetic resonance imaging, and compared these among different subgroups identified 
by migraine status. 
Results A cohort of 591 patients (male, 53.8%; mean age, 37.5±6.4 years) qualified for the analysis. 
Migraineurs had larger acute infarcts than non-migraineurs (median, 5.9 cm3 [interquartile range 
(IQR), 1.4 to 15.5] vs. 2.6 cm3 [IQR, 0.8 to 10.1], P<0.001), and the largest volumes were observed in 
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Introduction
Migraine is a chronic-intermittent primary headache disorder 
that affects roughly 15% of the Western population.1 Although 
migraine, in particular migraine with aura, has been shown to 
be associated to ischemic stroke,2 the exact mechanisms un-
derlying this relation remain unclear. 
Potential biologic processes include endothelial dysfunction, 
hypercoagulability, platelet aggregation, vasospasm, shared 
cardiovascular risk factors and genetic risk, paradoxical embo-
lism, and use of nonsteroidal anti-inflammatory drugs.3-8
Recent experimental evidence in mice has suggested that 
cerebral hyperexcitability and enhanced susceptibility to 
spreading depolarization, the electrophysiologic event underly-
ing migraine, may be one additional mechanism involved in the 
migraine-stroke association.9,10 The increased cerebral excit-
ability of migraineurs may facilitate infarction if and when the 
tissue becomes ischemic, by predisposing to frequent ischemic 
depolarizations. According to this pathogenic hypothesis, it 
might be that elevated cerebral blood flow threshold for viabil-
ity, a sign of increased vulnerability to ischemia, may promote 
rapid infarct expansion into tissue with milder perfusion defi-
cits, diminish salvageable tissue at risk, and result in larger in-
farcts in susceptible migraineurs. Currently, a paucity of data is 
available to substantiate this experimental model in clinical 
setting,11,12 and, in particular, whether patients with personal 
history of migraine actually develop larger infarct volumes has 
not been properly investigated so far. To explore this hypothe-
sis, in the present study we, therefore, sought to determine 
whether acute infarct volume, as well as the volume of chronic 
cerebral infarcts, assessed by volumetric magnetic resonance 
imaging (MRI) analysis, are associated with migraine and its 
subtypes in a large, prospective, hospital-based cohort of 
young patients with acute ischemic stroke.
Methods
Study design and study population
The Italian Project on Stroke at Young Age (IPSYS) is a country-
wide network of neurological centers with special interest in 
cerebral ischemia at young age across Italy, aimed at recruiting 
white patients with first-ever acute stroke who fulfill the fol-
lowing criteria: (1) age 18 to 45 years, (2) computed tomogra-
phy (CT)- or MRI-proven cerebral infarction, in the setting of a 
hospital-based, multicentre, observational study13 (Appendix 1). 
The study was approved by the local Ethics Committee. Written 
informed consent was obtained for all participants (or next of 
kin). Centers were included in the IPSYS network provided that 
the recruitment process of stroke cases takes place prospec-
tively. Stroke was defined as a sudden loss of global or focal 
cerebral function that persisted for >24 hours with a probable 
vascular cause.14 Ischemic stroke due to sinus venous thrombo-
sis, vasospasm after subarachnoid hemorrhage, cardiac surgery, 
occurring as an immediate consequence of trauma, and iatro-
genic strokes were excluded. The recruitment period for the 
present study was January 2006 through December 2015. 
Clinical and laboratory investigations
All patients underwent an etiologic workup including complete 
blood cell count, biochemical profile, urinalysis, 12-lead elec-
trocardiogram, chest roentgenography, Doppler ultrasonogra-
phy with frequency spectral analysis and B-mode echotomog-
raphy of the cervical arteries, transcranial Doppler ultrasonog-
raphy, and CT and/or magnetic resonance angiography to in-
vestigate extracranial and intracranial vessels. Coagulation 
testing included prothrombin and activated partial thrombo-
plastin times, circulating anti-phospholipid antibodies, fibrino-
gen, protein C, protein S, activated protein C resistance, anti-
thrombin III, genotyping to detect factor V Leiden and the 
G20210A mutation in the prothrombin gene. Transthoracic 
and/or transesophageal echocardiography were performed to 
rule out cardiac sources of emboli. Based on the results of such 
patients with migraine with aura (median, 9.0 cm3 [IQR, 3.4 to 16.6]). In a linear regression model, 
migraine was an independent predictor of increased log (acute infarct volumes) (median ratio [MR], 
1.64; 95% confidence interval [CI], 1.22 to 2.20), an effect that was more prominent for migraine 
with aura (MR, 2.92; 95% CI, 1.88 to 4.54). 
Conclusions These findings reinforce the experimental observation of larger acute cerebral infarcts 
in migraineurs, extend animal data to human disease, and support the hypothesis of increased 
vulnerability to ischemic brain injury in people suffering migraine.
Keywords Brain ischemia; Cortical spreading depression; Migraine disorders; Risk factors; Stroke
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investigations, patients were classified according to a classifi-
cation based on the Trial of Org 10172 in Acute Stroke Treat-
ment (TOAST) criteria, accommodated and validated for the 
cause of stroke in the young15 and divided into five etiologic 
categories: (1) atherosclerotic vasculopathy; (2) non-athero-
sclerotic vasculopathy; (3) small-vessel disease; (4) cardioem-
bolism; and (5) other: cerebral infarction that did not meet the 
criteria for one of the categories outlined.16
Potential confounders
Hypertension was defined as systolic blood pressure ≥140 mm 
Hg and diastolic pressure ≥90 mm Hg in two separate mea-
surements after the acute phase or use of antihypertensive 
drugs before recruitment. Diabetes mellitus as history of diabe-
tes mellitus, use of hypoglycemic agent or insulin, or fasting 
glucose ≥7.0 mmol/L. Smoking history was defined as “current 
smoking,” including former smokers who had quit smoking for 
6 months before the index event, versus “ever smoking” or 
“never smoking.” Hypercholesterolemia as cholesterol serum 
levels ≥5.7 mmol/L or use of cholesterol-lowering drugs. Cur-
rent use of oral contraceptives included current user as well as 
former users who had quit taking these medications for 1 
month before the index event. Family history of stroke was de-
fined when stroke was recorded in first-degree relatives by in-
terviewing probands or family members. We also collected in-
formation on heavy alcohol consumption (weekly consumption 
>14 drinks for men and >7 drinks for women), personal history 
of coronary artery disease (history of physician diagnosed an-
gina or myocardial infarction), and atrial fibrillation (medical 
history or electrocardiographic findings at admission).
MRI protocol 
Brain MRI scans were executed on 1.0- and 1.5-tesla scanners. 
Image analysis was applied to the MRI closest to the onset of 
clinical symptoms. The MRI protocols included turbo spin echo 
(TSE) and fluid-attenuated inversion recovery (FLAIR) T2-
weighted images and diffusion-weighted images acquired on 
axial plane and, where available, gradient echo (GE) T2*-
weighted images acquired on axial plane and three-dimensional 
time-of-flight (3D TOF)-magnetic resonance angiography imag-
es. For each image series, 20 slices covering the entire brain 
(matrix 240 – 256 × 256 – 320; field of view 22 to 24 cm; 
thickness 5 mm; interslice gap 1.5 mm) were obtained. Time 
repetition/time of echo/time of inversion/flip angle values were 
optimized on each scanner for the best available image contrast 
and resulted comparable across the centers. 
All MRI available in electronic format were collected, securely 
stored, and analysed centrally (Brescia University Hospital). An 
acute brain infarct was defined as a non-mass parenchymal de-
fect, hyperintense on T2, with a vascular distribution, with ele-
vated signal in high b-value diffusion-weighted MRI (DWI) im-
ages and low signal in apparent diffusion coefficient (ADC) maps. 
A chronic brain infarct was identified as non-mass lesion, isoin-
tense to cerebral-spinal fluid in all sequences, with low signal in 
high b-value DWI and an elevated signal in ADC maps. 
Image assessment
Magnetic resonance studies were evaluated by a neuroradiologist 
(M.B.) and a neurologist trained in neuroimaging (V.D.G.) who 
were blinded to the diagnosis and clinical data. For each patient, 
DWI confirmation of acute cerebral infarction was needed. 
Volumetric calculation of infarcted areas
Axial T2 fluid-FLAIR images were converted from Digital Imag-
ing and COmmunications in Medicine (DICOM) to analyze for-
mat for computer-assisted calculation of the infarct volume, 
using ANALYZE 11.0 (Mayo Clinic, Rochester, MN, USA). The In-
tensity Loaded Volume-Region of Interest function was used to 
optimize intensity settings, thereby enhancing contrast be-
tween gray and white matter, infarcted tissue and normal brain 
and assist in boundary definition. A region-of-interest map of 
brain infarcts was created by signal intensity thresholding on 
axial TSE/FLAIR images, followed by manual semiautomatic 
editing (Region of Interest module) and automatic calculation 
of the lesion volume. Number, location, and volume of acute, 
and chronic infarcts were recorded. 
Migraine assessment 
Personal history of headache was assessed in all participants 
by study physicians during a face-to-face interview with pa-
tients and/or family members in both acute phase and follow-
up evaluations. The diagnosis of migraine, as well as its sub-
types migraine without aura and migraine with aura was made 
according to the diagnostic criteria of the Headache Classifica-
tion Committee of the International Headache Society.17 
Statistical analyses
Infarct volumes were log-transformed for all analyses in this 
study. All variables were reported as either a mean value 
(±standard deviation), a median value with an interquartile 
range (IQR) or a proportion/percentage of total. For descriptive 
analyses, we compared patients characteristics by migraine 
subgroups (migraine vs. non-migraine; migraine without aura 
vs. migraine with aura vs. non-migraine) using the chi-square 
test, Median-test, and Anova F-test, as appropriate. Inter-rater 
reliability in MRI measurements was assessed by having the 
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two examiners categorize the same set of images in a sub-
group of 30 patients and was calculated using interclass corre-
lation (ICC) for single measures of acute volumes. The same 
approach was used to evaluate the reliability of volume calcu-
lation on FLAIR images versus DWI images. Using a linear re-
gression model of the log (acute infarct volume) values we as-
sessed the change in log-volumes of acute infarct volume as 
well as chronic infarct volume in patients with migraine (and 
its subtypes migraine without aura and migraine with aura) 
and migraine-free patients. Regression analyses were adjusted 
for covariates that reached a P<0.05 in univariate analysis. Be-
cause of their potential influence on final infarct volume we 
also planned to include the following variables in the model, 
regardless of their distribution in the two subgroups of patients 
defined by migraine status: (1) time from stroke onset to MRI; 
(2) presumed etiology of brain ischemia (categorized according 
to the TOAST criteria); (3) large vessel occlusion (occlusion vs. 
non-occlusion); (4) acute reperfusion therapy (intravenous tis-
sue plasminogen activator and/or mechanical thrombectomy 
vs. no reperfusion therapy); (5) arterial recanalization (com-
plete recanalization [defined as a Thrombolysis in Cerebral In-
farction score of IIb or higher at the end of the endovascular 
procedure18] vs. other). To explore potential effect measure 
modification, we also performed analyses stratified by sex. Re-
sults are given as exp (beta)=median ratios (MRs) with 95% 
confidence intervals (CI). P≤0.05 on 2-sided test was consid-
ered significant. Data were analyzed using the SPSS version 
21.0 software package (IBM Co., Armonk, NY, USA).
Results
Fourteen of the 22 centers included in the IPSYS network partic-
ipated to the present imaging study. The remaining eight centers 
were unable to obtain endorsement of the MRI analysis by the 
local health authority. In all, 600 patients qualified for the study. 
Nine of these were excluded due to presence of contraindica-
tions for MRI scan (e.g., pregnancy, claustrophobia, cardiac elec-
tronic devices; n=3), because they died before brain MRI was 
performed (n=2), or because magnetic resonance images were 
not suitable for volumetric measurement due to poor quality 
(n=4). Hence, data from 591 patients (male, 53.8%; mean age, 
37.5±6.4 years) were entered into the analysis. Of these, 160 
(27.0%) had a personal history of migraine (migraine without 
aura/migraine with aura, 103/57). Migraineurs were similar to 
non-migraine patients with regard to demographic characteris-
tics and risk factors, although females were more prevalent in 
the former subgroup and they also reported to assume oral con-
traceptives at a higher percentage. Also, the prevalence of heavy 
alcohol consumers among migraineurs was lower compared with 
that among non-migraineurs. The etiologic categories “cardiac 
embolism” and “other or undetermined etiology” were the most 
represented among patients suffering migraine (Table 1). 
 Interobserver agreement was good for acute infarct volumes 
(ICC coefficient, 0.89; 95% CI, 0.78 to 0.95). Similarly, there was 
a good agreement for volume measurements on FLAIR images 
and DWI images (ICC coefficient, 0.83; 95% CI, 0.65 to 0.92). In 
univariate analysis, patients with personal history of migraine 
had larger acute infarct lesions than patients with no history of 
migraine (median, exp [8.69]/103=5.9 cm3 [IQR, 1.4 to 15.5] vs. 
exp [7.87]/103=2.6 cm3 [IQR, 0.8 to 10.1]; P<0.001). In particular, 
the largest volumes were observed in the subgroup of patients 
with migraine with aura (median, exp [9.11]/103=9.0 cm3 [IQR, 
3.4 to 16.6] vs. exp [8.2]/103=3.6 cm3 [IQR, 1.0 to 14.4] in pa-
Table 1. Demographic and clinical characteristics of study participants by 
migraine status
Characteristic Migraine (n=160)
Non-migraine 
(n=431)
P
Age (yr) 36.7±6.2 37.1±6.5 0.443
Male sex 69 (43.1) 249 (57.8) 0.002
Hypertension 28 (17.5) 97 (22.5) 0.185
Diabetes 5 (3.1) 19 (4.4) 0.482
Hypercholesterolemia 50 (31.3) 107 (24.8) 0.116
Current smoking 54 (33.8) 174 (40.8) 0.142
Oral contraceptives* 42 (46.2) 60 (33.0) 0.046
Family history of stroke 34 (21.3) 86 (20.0) 0.728
Atrial fibrillation 2 (1.3) 2 (0.5) 0.297
Cardiac interatrial right-to-
left shunt
90 (56.3) 116 (26.9) <0.001
Heavy alcohol consumption 15 (9.4) 73 (16.9) 0.022
Cause of stroke 0.369
Large-vessel disease 13 (8.1) 45 (10.4)
Non-atherosclerotic vas-
culopathies
32 (20.0) 60 (13.9)
Small-vessel disease 14 (8.8) 49 (11.4)
Cardiac embolism 50 (31.3) 132 (30.6)
Other or undetermined 
etiology
51 (31.9) 145 (33.6)
Large artery occlusion 12 (7.5) 35 (8.1) 0.866
IV thrombolysis/endovascu-
lar treatment 
17 (10.6) 34 (7.9) 0.323
Vessel recanalization 8 (5.0) 27 (6.3) 0.696
Time from stroke onset to 
MRI (hr)
32.5 (24.0–45.5) 36.0 (24.0–48.0) 0.167
Values are presented as mean±standard deviation, number (%), or median 
(interquartile range).
IV, intravenous; MRI, magnetic resonance imaging.
*In females.
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tients with migraine without aura; P<0.001) (Figure 1).
 These results were apparently not influenced by specific mi-
graine characteristics (i.e., migraine activity and pain severity), 
though this comparison was possible only in a small subgroup 
of patients (Supplementary Table 1). In the linear regression 
model of log(acute infarct volume) values including age, alco-
hol consumption, as well as all the variables with a potential 
influence on final infarct volume as covariates, a personal his-
tory of migraine was an independent predictor of increased 
acute infarct volumes (P<0.001). Lesion size, in particular, 
turned out to be more than once and a half as large in this 
group compared to the group of patients with no history of 
migraine (MR, 1.80; 95% CI, 1.33 to 2.45). Similarly, the sub-
type migraine with aura was independently associated with in-
creased acute infarct size in the model including migraine sub-
types, lesion volumes being more than 3 and a half times larger 
in this group in comparison with the reference group of pa-
tients with no migraine (MR, 3.62; 95% CI, 2.28 to 5.74). These 
findings were consistent across sexes (Table 2). 
 As further support to these findings, we observed an in-
crease of the proportion of patients with any migraine as well 
as with migraine with aura, and a decrease of the proportion 
of those with no history of migraine, with increasing quartiles 
of log (acute infarct volumes) (P for trend <0.001) (Figure 2). 
 Chronic brain infarcts were present in 75 cases (12.7%). The 
volumes of these silent lesions did not differ significantly be-
tween patients with migraine (median, exp [7.31]/103=1.5 cm3 
[IQR, 0.4 to 4.7]) and patients who did not suffer migraine (me-
dian, exp [6.91]/103=1.0 cm3 [IQR, 0.3 to 3.0]), as well as across 
migraine subtypes (median, exp [7.74]/103=2.3 cm3 [IQR, 1.4 to 
14.9] in patients with migraine with aura vs. exp [6.81]/103=0.9 
cm3 [IQR, 0.04 to 5.0] in patients with migraine without aura). 
Figure 1. Box-plots of log (acute infarct volume) values by migraine sub-
groups. In the box-plot the central rectangle spans the first quartile to the 
third quartile (interquartile range). A bold segment inside the rectangle 
shows the median and “whiskers” above and below the box show the loca-
tions of the minimum and maximum; outside box-plot points are outliers.
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Table 2. MRs estimates of log (acute infarct volumes) values by linear regression
Characteristic
MR Adjusted MR
95% CI P 95% CI P
Entire cohort
Any migraine vs. no migraine 1.74 (1.30–2.35) 2.7×10-4 1.80 (1.33–2.45)* ≤0.001
Migraine without aura vs. no migraine 1.28 (0.90–1.82) 0.162 1.29 (0.91–1.82)* 0.157
Migraine with aura vs. no migraine 3.04 (1.94–4.76) 1.7×10-6 3.62 (2.28–5.74)* 7.3×10-8
Male
Any migraine vs. no migraine 1.77 (1.16–2.72) 0.009 1.95 (1.24–3.06)* 0.003
Migraine without aura vs. no migraine 1.41 (0.84–2.35) 0.193 1.40 (0.83–2.35)* 0.205
Migraine with aura vs. no migraine 2.66 (1.38–5.14) 0.003 3.76 (1.89–7.49)* ≤0.001
Female
Any migraine vs. no migraine 1.59 (1.04–2.42) 0.033 1.64 (1.07–2.52)† 0.024
Migraine without aura vs. no migraine 1.10 (0.68–1.79) 0.696 1.14 (0.70–1.84)† 0.598
Migraine with aura vs. no migraine 3.11 (1.67–5.78) 4.2×10-4 3.52 (1.87–6.62)† ≤0.001
MR, median ratio; CI, confidence interval.
*Adjusted by age, alcohol consumption, time from stroke onset to magnetic resonance imaging, presumed etiology of brain ischemia (categorized according to 
the Trial of Org 10172 in Acute Stroke Treatment [TOAST] criteria), patent foramen ovale, large vessel occlusion (occlusion vs. non-occlusion), acute reperfu-
sion therapy (intravenous tissue plasminogen activator and/or mechanical thrombectomy vs. no reperfusion therapy), and arterial recanalization (complete re-
canalization [Thrombolysis in Cerebral Infarction score of IIb or higher at the end of the endovascular procedure18] vs. other); †Adjusted as in males (*) and oral 
contraceptive use.   
Vol. 21 / No. 3 / September 2019
https://doi.org/10.5853/jos.2019.00332 http://j-stroke.org 329
Discussion
In a large series of young patients with ischemic stroke, we 
have shown that people suffering migraine, especially the sub-
type migraine with aura, are at risk of developing larger acute 
brain infarcts, though the burden of silent ischemic lesions 
does not differ in migraineurs compared with non-migraineurs, 
nor across migraine subtypes. The data presented here provide 
evidence that reinforces the experimental observation of a 
more rapid expansion of the acute ischemic core and, eventu-
ally, the development of larger infarcts in transgenic mouse 
models expressing familial hemiplegic migraine type 1 (FHM1) 
mutations,9 and extend the results of previous preliminary 
works, including ours,11,12 linking individual migraine status 
with increase vulnerability to ischemic brain injury in humans. 
The association between migraine and stroke has been sub-
ject of considerable debate. Between 2005 and 2018, four me-
ta-analyses included studies involving any stroke and ischemic 
stroke as outcomes.2,19-21 In two of them, the overall risk of 
stroke was higher in migraineurs.2,19 Additionally, three consec-
utive meta-analyses showed that migraine with aura is consis-
tently associated with a more than 2-fold increased risk of 
ischemic stroke.2,20,21 Such a risk was also around 3-fold higher 
among women younger than 45 years,2,20 9-fold higher among 
current smokers,2 and 7-fold higher among women taking oral 
contraceptives.2,20 More recently, data from Atherosclerosis Risk 
in Communities (ARIC) study suggested increased incidence of 
atrial fibrillation and cardioembolic stroke in older migraineurs 
with visual aura,22 especially among subjects with late onset 
migraine with aura.23 Taken together, despite some conflicting 
evidence,24-26 these findings and our own results support the 
prevailing idea that migraine is a highly prevalent and perhaps 
modifiable predisposing factor for brain ischemia, though the 
exact mechanisms underlying this relationship remain to be 
clarified. Several biologic pathways implicated in cerebral 
blood vessel dysfunction have been advocated, including hy-
percoagulable states, inflammation, platelet and white blood 
cell endothelial interactions, among the others.27 It might be 
possible that these mechanisms play also a role in the relation 
between migraine and infarct growth in combination with an 
underlying condition of increased susceptibility to brain isch-
emia of migraineurs, thus lending indirect support to the hy-
pothesis of a common pathophysiology for the two diseases, at 
least in a subset of patients.
Whether migraine may result in increased acute infarct vol-
ume outside of the experimental settings has not been properly 
investigated so far. Actually, only two previous analyses have 
attempted to provide information on the association between 
migraine and lesion volume from acute cerebral ischemia in 
humans. The first is a retrospective analysis of the Norwegian 
Stroke Research (NORSTROKE) registry,28 which suggested that, 
as opposed to what observed in our study, migraine may be as-
sociated with smaller volume of acute infarcts. The second is a 
single-center North American study conducted on a relatively 
small group of acute ischemic stroke patients showing, as sug-
gested from the present analysis, an increased lesion volume 
among migraineurs with aura.29 The reason for these conflict-
ing results may be due, at least to some extent, to method-
ological issues. As admitted by the authors themselves, the re-
sults of the first analysis might be biased by the lack of a rigor-
ous imaging-based volumetric measurement of the brain le-
sions as well as by the huge number of patients excluded be-
Figure 2. Histogram of percentage of subjects in each quartile of acute infarct volume according to migraine status: (A) any migraine vs no migraine; (B) mi-
graine without aura vs. migraine with aura vs. no migraine. 
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cause of more severe stroke symptoms, likely reflecting large 
infarct size. Also, because of their demographic characteristics, 
participants to the NORSTROKE registry are probably not the 
ideal population to investigate. Similarly, the lack of relevant 
information on clinical and imaging features of the study 
group, an unavoidable consequence of its characteristics of 
preliminary report, represents the major shortcoming of the 
second study and limits the interpretation and generalizability 
of its findings. Contrary to these previous reports, our study 
was carried out to test the specific a priori hypothesis on a 
large number of well-characterized young patients with acute 
ischemic stroke, migraine status was assessed through direct 
interview with physicians according to internationally ac-
knowledged criteria, and the same MRI protocol for infarct 
volume measurement was applied to all study participants. 
Further strengths of our study include its prospective nature, 
the central analysis of brain images, and the high interobserver 
agreement on the measurement of lesion volume. 
On the other hand, there are some potential limitations of 
our analysis worthy of consideration. First, since we did not as-
sess migraine frequency and severity or the frequency of auras, 
we cannot evaluate whether the observed association differs 
according to specific migraine patterns. However, whether the 
clinical features of migraine have any influence on the individ-
ual risk of stroke has never been demonstrated. Also, we did 
not have information on migraine-specific prophylactic drug 
use, such as, for example, the use of topiramate or lamotrigine, 
which has been suggested in previous experimental models to 
protect migraineurs against ischemic injury.30 Second, we as-
sessed migraine history by self-report, which raises the possi-
bility of recall bias, creating the potential for misclassification 
of exposure. This is, however, an unavoidable feature of any 
epidemiologic study on the relation between migraine and 
stroke. Third, we cannot exclude that infarct size might depend 
on other, undetected or hitherto unknown, factors of which 
migraine is only a marker or an epiphenomenon. Even in this 
case, however, the hypothesis of a relation between migraine 
and infarct volume would still be valid and support the exter-
nal validity of our results. Finally, since participants in this 
study were aged 18 to 45 years and white, generalizability to 
other populations might be limited. 
Conclusions
With this caveat in mind, we conclude that the present results 
support the experimental observations in mice and the sparse 
data in humans that a personal history of migraine is associat-
ed to larger acute infarct volumes, probably through a condi-
tion of migraine-associated cerebral hyperexcitability, point 
toward the possibility that this may be one of the biologic 
mechanisms underlying the migraine-stroke association, and 
indirectly strengthen the testable hypothesis that treatment 
aimed at inhibiting cerebral spreading depolarization might 
protect migraineurs at risk of stroke.
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Poli, Valeria De Giuli, Filomena Caria, Alessandro Padovani)
Neurology Unit, Istituti Ospitalieri, Cremona, Italy (Alessia Giossi, Maria Sessa)
 
Stroke Unit, Vascular Neurology, “Spedali Civili”, Brescia, Italy (Massimo Gamba, Mauro Magoni)
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Stroke Unit, Neurological Clinic, Nuovo Ospedale Civile “S. Agostino Estense”, AUSL, Modena, Italy (Andrea Zini, Anna Maria Simone, 
Stefania Maffei, Guido Bigliardi, Mauro Gentile, Maria Luisa Dell’Acqua, Francesca Rosafio, Roberta Pentore, Paolo Frigio Nichelli)
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Stroke Unit, Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy (Maurizio Paciaroni, Valeria Caso, Cataldo 
D’Amore, Giancarlo Agnelli)
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Neurology Unit, "Cà Foncello" Hospital, ULSS 9, Treviso, Italy (Simone Tonello, Marco Domenico Bonifati)
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Supplementary Table 1. Relation between infarct volumes, migraine activity, and pain severity
Variable Median (IQR) P
Migraine 1.000
Active migraine 9.06 (1.47–12.14)
Inactive migraine 8.50 (3.15–19.45)
VAS* 0.637
<7 9.06 (1.47–15.89)
≥7 8.50 (1.28–17.14)
Data were obtained from a subgroup of 35 patients. Active migraine was defined as at least one migraine attack in the year prior to index stroke; inactive mi-
graine was defined as personal history of migraine but no migraine attacks in the year prior to index stroke. 
IQR, interquartile range; VAS, visual analogic scale. 
*Self-reported pain intensity, ranging from 0 (no pain) to 10 (maximum pain severity).
